{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:34:56Z","timestamp":1789594496784,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pop.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:53:36Z","timestamp":1601081616000},"page":"597-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Nephrotic Syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Seth Anthony","family":"Politano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gates B.","family":"Colbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Hamiduzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pop.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ndt\/gfx189","article-title":"Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey","volume":"33","author":"O\u2019Shaughnessy","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The Global Epidemiology of Diabetes and Kidney Disease","volume":"25","author":"Koye","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"10.1016\/j.pop.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.pop.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.ajkd.2016.03.416","article-title":"Distribution of Biopsy-Proven Presumed Primary Glomerulonephropathies in 2000-2011 Among a Racially and Ethnically Diverse US Population","volume":"68","author":"Sim","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.pop.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary Membranous Nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.002_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-019-1544-2","article-title":"Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis","volume":"20","author":"Liang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.pop.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986\u20132015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal Change Disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408360801934865","article-title":"Recent progress in the pathogenesis of nephrotic proteinuria","volume":"45","author":"Tesar","year":"2008","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.pop.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/apha.12047","article-title":"Mechanisms of renal NaCl retention in proteinuric disease","volume":"207","author":"Svenningsen","year":"2013","journal-title":"Acta Physiol"},{"issue":"6","key":"10.1016\/j.pop.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"van de Logt","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2020.08.002_bib12","series-title":"Comprehensive Clinical Nephrology","author":"Johnson","year":"2018"},{"issue":"3","key":"10.1016\/j.pop.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.002_bib14","first-page":"1482","article-title":"Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency?","volume":"82","author":"Colle","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pop.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"916760","DOI":"10.1155\/2014\/916760","article-title":"Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism: an up-to-date review of the literature","volume":"2014","author":"Mirrakhimov","year":"2014","journal-title":"Int J Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrneph.2017.175","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.pop.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.14140121","article-title":"Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT","volume":"273","author":"Zhang","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.pop.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.pop.2020.08.002_bib19","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170647","article-title":"Transcription and translation of APOL1 variants","volume":"37","author":"Ejaz","year":"2017","journal-title":"Biosci Rep"},{"issue":"3","key":"10.1016\/j.pop.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14797\/mdcj-8-3-3","article-title":"The amyloidoses: clinical features, diagnosis and treatment","volume":"8","author":"Baker","year":"2012","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"5","key":"10.1016\/j.pop.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.ajkd.2008.08.009","article-title":"Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study","volume":"53","author":"Menon","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.pop.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"issue":"10008","key":"10.1016\/j.pop.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pop.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1440-1797.2003.00143.x","article-title":"Atorvastatin in dyslipidaemia of the nephrotic syndrome","volume":"8","author":"Valdivielso","year":"2003","journal-title":"Nephrology (Carlton)"},{"issue":"1\u20132","key":"10.1016\/j.pop.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000357476","article-title":"Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus","volume":"93","author":"Dworacka","year":"2014","journal-title":"Pharmacology"},{"issue":"8","key":"10.1016\/j.pop.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2020.08.002_bib31","article-title":"Prophylactic Anticoagulation in Adult Patients with Nephrotic Syndrome","author":"Gordon-Cappitelli","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.pop.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/0886022X.2011.553301","article-title":"Acute kidney injury in adult idiopathic nephrotic syndrome","volume":"33","author":"Chen","year":"2011","journal-title":"Ren Fail"},{"issue":"4","key":"10.1016\/j.pop.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5414\/CNP62245","article-title":"Complications of the nephrotic syndrome and their treatment","volume":"62","author":"Crew","year":"2004","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00864400","article-title":"Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome","volume":"7","author":"Vaziri","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pop.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:21Z","timestamp":1758815001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454320300567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0095454320300567"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.002","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}